US Remote Patient Monitoring Market Supportive Regulatory Frameworks for AI-Enabled Wearable Devices to Drive Growth

The global remote patient monitoring (RPM) market is entering a period of rapid transformation and expansion, with a projected valuation of US$56.94 billion by 2030, rising from US$27.72 billion in 2024. This represents a robust CAGR of 12.7% from 2024 to 2030, according to the latest market analysis. Key factors fueling this growth include the rising prevalence of chronic diseases, shifting consumer preferences toward home healthcare, the surge in wearable device adoption, and the broader digital transformation of healthcare systems worldwide.

Download PDF brochure of Remote Patient Monitoring Market

Government-led initiatives are also catalyzing growth. Programs such as the FCC’s COVID-19 Telehealth Program and the Rural Health Care Program are bridging gaps in broadband access, particularly in underserved and rural regions, enabling healthcare providers to extend RPM services to patients who were previously left behind.

While the COVID-19 pandemic acted as a strong catalyst for telehealth adoption, experts caution that critical hurdles—including infrastructure readiness, digital literacy, and reimbursement challenges—still need to be addressed for the technology to reach its full potential.

Market Drivers: Transforming Patient Care Through Digital Innovation

Remote patient monitoring is fundamentally reshaping patient care models by leveraging digital tools to collect, transmit, and analyze patient health data in real-time. These capabilities enable proactive interventions, improved chronic disease management, and reduced hospital readmissions. For patients with conditions such as heart disease, diabetes, and hypertension—particularly those in remote or underserved areas—RPM delivers life-changing benefits.

The momentum for RPM adoption is visible in insurance and policy trends. Medicare beneficiaries’ RPM use grew more than sixfold between 2018 and 2021, with 594 monthly claims per 100,000 enrollees in 2021. By March 2023, 34 state Medicaid programs covered RPM, though coverage restrictions remain in some jurisdictions.

In parallel, the integration of AI-powered diagnostic tools is accelerating adoption. Over 103 AI-enabled devices targeting conditions such as sleep apnea, atrial fibrillation, and epilepsy are already deployed, with 75 FDA-approved AI/ML tools in the U.S. market.

The rise of mHealth solutions is another accelerant. By combining wearable devices, biosensors, and telehealth software, mHealth platforms deliver real-time monitoring. In the U.S., billing for remote physiological monitoring grew five-fold in just three years, while codes for remote therapeutic monitoring quadrupled in 2023. Demand spans beyond traditional chronic disease management, extending into obesity, mental health, and musculoskeletal care.

Industry leaders such as Accuhealth, Biofourmis, Teladoc Health, and Omron Healthcare are spearheading this innovation wave, reinforcing RPM’s role as an indispensable element of modern healthcare ecosystems.

Market Restraints: High Investment Costs and IT Expertise Gaps

Despite its promise, RPM adoption faces structural challenges. Healthcare providers—especially small practices and underfunded organizations—often lack the IT infrastructure required to support sophisticated RPM platforms. Full-scale implementation requires substantial investments in data storage, integration with electronic health records (EHRs), and ongoing system updates.

Approximately one-third of RPM ownership costs are allocated to system support and updates, making it a resource-intensive endeavor. Moreover, organizations without specialized IT staff must invest heavily in employee training, further straining budgets.

For hospitals reliant on complex networks connecting laboratories, physicians, and outpatient centers, shifting to cloud-based care management systems often requires disruptive IT architecture modifications. This barrier significantly impacts scalability, particularly in large, multi-site healthcare networks.

Opportunities: Rising Demand in Outpatient Care Environments

A clear growth frontier for RPM lies in the global shift toward outpatient care. Outpatient procedures cost 30–60% less than inpatient treatments, offering both affordability and convenience. This cost advantage, coupled with improved patient experiences, is fueling demand.

By 2024, the U.S. had over 6,300 Medicare-certified ambulatory surgical centers (ASCs), reflecting a significant transition toward outpatient care. Between 2014 and 2020, Medicare payments for ASC procedures grew by 29%, underscoring this momentum.

RPM technology aligns seamlessly with this shift, enabling continuous monitoring, coordinated care, and timely interventions—all of which reduce readmission rates.

Government support is amplifying the trend. In 2021, the U.S. invested US$80 million in public health informatics, advancing integration of digital health tools into outpatient delivery models. Meanwhile, Medicare reimbursements for ASCs increased by 3.8%, encouraging providers to invest in innovative monitoring solutions.

Challenges: Addressing Social Determinants of Health (SDOH)

For RPM to deliver equitable care, social and demographic barriers must be addressed. Digital health disparities—driven by language barriers, broadband availability, geographic isolation, and socioeconomic status—pose significant challenges.

For example, a NYU Langone Health study revealed that 28.3% of Spanish-speaking patients did not use RPM tools for blood pressure monitoring. Broadband inequities exacerbate this issue, with 8.3 million U.S. households still lacking access. Rural hospitals, which serve many of these communities, are 33.5% less likely to adopt RPM solutions.

Furthermore, studies indicate that Hispanic and Black patients engage less consistently with RPM programs due to technical barriers, mistrust, or limited digital literacy. Closing these gaps is crucial to avoid widening health disparities and ensuring that RPM serves all populations equitably.

Market Segmentation Insights

By End-User: Hospitals dominated the RPM market in 2023, driven by rising chronic disease cases, healthcare reforms such as the Affordable Care Act, and surging demand for data-driven patient management. Hospitals generate millions of data points daily from monitoring devices, fueling demand for advanced storage and analytics.

Example: PainChek (Australia) partnered with InterSystems Corporation (U.S.) in November 2022 to integrate mobile pain assessment tools into EMR systems, enhancing hospital use cases.

By Transmission Type: The synchronous RPM segment is poised for the fastest growth, reflecting increasing demand for real-time monitoring and rapid intervention. AI and machine learning will further enhance these solutions, enabling faster and more accurate diagnoses.

By Region: While North America leads today, Asia Pacific is expected to register the highest growth through 2030. Rising healthcare expenditure, large populations, an aging demographic, and rapid digital adoption in countries like India and China are fueling expansion.

Example: Researchers at the Jawaharlal Nehru Centre for Advanced Scientific Research (India) recently developed a silver-wired wearable device capable of detecting stress in real-time, highlighting regional innovation.

Recent Industry Developments

Medtronic (Ireland) launched the MyCareLink Smart Monitor in January 2025, the world’s first app-based pacemaker remote monitoring solution.

GE HealthCare (U.S.) introduced the Venue Sprint portable ultrasound system with AI integration in September 2024.

Philips (Netherlands) partnered with Bon Secours Mercy Health (U.S.) in July 2024 to scale RPM platforms across 49 hospitals and 1,200 care sites.

Omron Healthcare (Japan) acquired Luscii healthtech (Netherlands) in April 2024, accelerating its strategy to reduce cardiovascular and cerebrovascular events under its "Going for Zero" vision.

Key Market Players

The competitive landscape features global leaders and innovative disruptors, including:

Koninklijke Philips N.V. (Netherlands)

Medtronic (Ireland)

OMRON Corporation (Japan)

GE Healthcare (U.S.)

Oracle (U.S.)

Boston Scientific Corporation (U.S.)

Abbott (U.S.)

Siemens Healthineers AG (Germany)

Teladoc Health, Inc. (U.S.)

Biotronik (Germany)

Baxter (U.S.)

Biobeat (Israel)

VitalConnect (U.S.)

VivaLNK, Inc. (U.S.)

Optum, Inc. (U.S.)

Clear Arch, Inc. (U.S.)

Lightbeam (U.S.)

Guangdong Transtek Medical Electronics Co., Ltd (China)

Conclusion

The remote patient monitoring market is on a trajectory of sustained growth, underpinned by healthcare digitalization, AI integration, and patient-centric care models. While significant challenges remain—particularly in terms of cost, IT infrastructure, and health equity—the long-term outlook is one of strong adoption and innovation.

With governments, insurers, and providers increasingly aligned in their support of RPM solutions, the sector is poised to revolutionize healthcare delivery, bridging the gap between patients and providers and enabling continuous, proactive, and personalized care.